Cloud provider CoreWeave to buy Core Scientific in $9bn deal

Cloud infrastructure firm CoreWeave is set to acquire Core Scientific in an all-stock deal valued at approximately $9 billion, significantly expanding its data center footprint and control over critical power resources. This strategic move aims to accelerate CoreWeave's deployment of AI and high-performance computing (HPC) workloads by securing 1.3GW of gross power with substantial expansion potential, while also streamlining operations and realizing cost efficiencies. Core Scientific shareholders will receive 0.1235 newly issued CoreWeave Class A common shares per share, resulting in them owning less than 10% of the combined entity upon the transaction's expected close in Q4 2025, subject to regulatory and shareholder approvals.

Analysis

CoreWeave is executing a strategic vertical integration with its planned $9 billion all-stock acquisition of Core Scientific, aimed at securing critical infrastructure for the rapidly growing AI and High-Performance Computing (HPC) sectors. The transaction provides CoreWeave with control over approximately 1.3GW of gross power across Core Scientific's data center network, with a significant pipeline for over 1GW of additional expansion. This move is designed to de-risk future growth by internalizing the foundational layer of its platform, which management believes will enhance operating efficiency and lower costs through streamlined operations and reduced lease overhead. For Core Scientific shareholders, the deal offers 0.1235 newly issued CoreWeave shares for each of their shares, resulting in them owning less than 10% of the combined entity post-transaction. The deal, which has board approval from both companies, faces a lengthy closing period until Q4 2025, contingent upon regulatory and Core Scientific shareholder approvals.

Key Decisions for Investors

• Core Scientific (CORZ) investors should evaluate the all-stock deal based on their outlook for CoreWeave's valuation, as their return is now directly linked to CRWV's performance and the fixed exchange ratio, leading to a minority stake of under 10% in the combined entity.
• For stakeholders in CoreWeave (CRWV), this acquisition represents an aggressive but strategic move to secure its supply chain for AI infrastructure, potentially solidifying its competitive position by controlling power capacity, though they must consider the dilutive effect of the all-stock transaction and the execution risk of integrating Core Scientific's assets.
• Investors in both entities must factor in the significant timeline risk, as the targeted Q4 2025 closing is subject to regulatory scrutiny and potential shareholder resistance, making the deal's completion and final value uncertain over the interim period.